Functionalized nanoscale graphene oxide for high efficient drug delivery of cisplatin

Journal of Nanoparticle Research

Volumn 16, Issue 11, 2014, Pages

  Tian, Lingyang ^a,b   Pei, Xibo ^a,b   Zeng, Yongxiang ^a,b   He, Rui ^a,b   Li, Zhongjie ^a,b   Wang, Jian ^a,b   Wan, Qianbing ^a   Li, Xiaoyu ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Chemotherapy; Cisplatin; Drug delivery; Graphene oxide; Nanomedicine

Indexed keywords

ATOMIC FORCE MICROSCOPY; CELL PROLIFERATION; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; EFFICIENCY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GRAPHENE; GRAPHENE OXIDE; MEDICAL NANOTECHNOLOGY; NANOSTRUCTURED MATERIALS; PLATINUM COMPOUNDS; TARGETED DRUG DELIVERY; TRANSMISSION ELECTRON MICROSCOPY;

CARBOXYLIC GROUP; CIS-PLATIN; COVALENT REACTION; DRUG DELIVERY VEHICLES; FLUORESCENT IMAGES; HUMAN BREAST CANCER; LOADING EFFICIENCY; OXYGEN CONTAINING GROUPS;

CONTROLLED DRUG DELIVERY;

CARBOXYLIC ACID; CISPLATIN; GRAPHENE OXIDE; MACROGOL 2000;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; CARCINOMA CELL LINE; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MCF 7 CELL LINE; RAMAN SPECTROMETRY; SUSTAINED DRUG RELEASE; THICKNESS;

EID: 84912551757     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-014-2709-3     Document Type: Article

References (61)

1. Ajima K, Yudasaka M, Murakami T et al (2005) Carbon nanohorns as anticancer drug carriers. Mol Pharm 2:475–480
2. Ajima K, Yudasaka M, Maigné A et al (2006) Effect of functional groups at hole edges on cisplatin release from inside single-wall carbon nanohorns. J Phys Chem B 110:5773–5778
3. Ajima K, Murakami T, Mizoguchi Y et al (2008) Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns. ACS Nano 2:2057–2064
4. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–1822
5. Bai H, Li C, Wang X et al (2010) A pH-sensitive graphene oxide composite hydrogel. Chem Commun (Camb) 46:2376–2378
6. Boulikas T, Vougiouka M (2003) Cisplatin and platinum drugs at the molecular level (review). Oncol Rep 10:1663–1682
7. Brown SD, Nativo P, Smith JA et al (2010) Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 132:4678–4684
8. Chabner BA, Allegra CJ, Curth GA (1996) “Antineoplastic agents: pyrimidine analogs”. In: Hardman JG et al. (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 9th edn. New York, McGraw-Hill 1247–1251
9. 4nanoparticles and graphene oxide for cellular magnetic resonance imaging. ACS Appl Mater Interfaces 3:4085–4091
10. Ciobotaru CC, Damian CM, Matei E et al (2014) Covalent functionalization of graphene oxide with cisplatin. Mater Plast 51:75–80
11. da Lee Y, Khatun Z, Lee JH et al (2011) Blood compatible graphene/heparin conjugate through noncovalent chemistry. Biomacromolecules 12:336–341
12. Depan D, Shah J, Misra RDK (2011) Controlled release of drug from folate-decorated and graphene mediated drug delivery system: synthesis, loading efficiency, and drug release response. Mater Sci Eng 31:1305–1312
13. Dhar S, Gu FX, Langer R et al (2008) Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci USA 105:17356–17361
14. Feazell RP, Nakayama-Ratchford N, Dai H et al. (2007) Soluble single-walled carbon nanotubes as longboat delivery systems for platinum (IV) anticancer drug design. J Am Chem Soc 129: 8438
15. Gabizon AA (2001) Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet. Clin Cancer Res 7:223–225
16. Geim AK, Novoselov KS (2007) The rise of graphene. Nat Mater 6:183–191
17. Gillies ER, Frechet JM (2003) A new approach towards acid sensitive copolymer micelles for drug delivery. Chem Commun (Camb) 14:1640–1641
18. Haxton KJ, Burt HM (2009) Polymeric drug delivery of platinum-based anticancer agents. J Pharm Sci 98:2299–2316
19. 4nanoparticles to graphene oxide by covalent bonding. Carbon 48:3139–3144
20. Hilder TA, Hill JM (2007) Modelling the encapsulation of the anticancer drug cisplatin into carbon nanotubes. Nanotechnology 18:275704
21. Hu H, Yu J, Li Y et al (2012) Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. J Biomed Mater Res Part A 100:141–148
22. Kim JH, Kim YS, Park K et al (2008) Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release 127:41–49
23. Konishi M, Tabata Y, Kariya M et al (2003) In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Control Release 92:301–313
24. Lee SC, Kim C, Kwon IC et al (2003) Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J Control Release 89:437–446
25. Lei H, Mi L, Zhou X et al (2011) Adsorption of double-stranded DNA to graphene oxide preventing enzymatic digestion. Nanoscale 3:3888–3892
26. 4/graphene composites with high lithium storage capacity and for controlled drug delivery. J Phys Chem C 115:21567–21573
27. Liu Z, Liang XJ (2012) Nano-carbons as theranostics. Theranostics 2:235–237
28. Liu Z, Robinson JT, Sun X et al (2008) PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 130:10876–10877
29. Liu Z, Robinson JT, Tabakman SM et al (2011) Carbon materials for drug delivery and cancer therapy. Mater Today 14:316–323
30. Maeda H, Matsumura Y (1989) Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 6:193–210
31. Makharza S, Cirillo G, Bachmatiuk A et al (2013) Graphene oxide-based drug delivery vehicles: functionalization, characterization, and cytotoxicity evaluation. J Nanopart Res 15:2099
32. Malik M, Michalska D (2014) Assessment of new DFT methods for predicting vibrational spectra and structure of cisplatin: which density functional should we choose for studying platinum (II) complexes? Spectrochimi Acta A 125:431–439
33. Martindale W (1996) The extra pharmacopoeia. In: Reynolds JEF (ed), 31st edn. London: Pharmaceutical Press 552
34. Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–6392
35. Mellman I, Fuchs R, Helenius A (1986) Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 55:663–700
36. Mizumura Y, Matsumura Y, Hamaguchi T et al (2001) Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity. Jpn J Cancer Res 92:328–336
37. Nishiyama N, Yokoyama M, Aoyagi T et al (1999) Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum (II) and poly(ethylene glycol)-poly(aspartic acid) block copolymer in an aqueous medium. Langmuir 15:377–383
38. Nishiyama N, Okazaki S, Cabral H et al (2003) Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 63:8977–8983
39. Oberoi HS, Laquer FC, Marky LA et al (2011) Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloroplatinum (II). J Control Release 153:64–72
40. OuYang F, Huang B, Li Z et al (2008) Chemical functionalization of graphene anoribbons by carboxyl groups on Stone-Wales defects. J Phys Chem C 112:12003–12007
41. Paredes JI, Villar-Rodil S, Martinez-Alonso A et al (2008) Graphene oxide dispersions in organic solvents. Langmuir 24:10560–10564
42. Pratt WB, Ruddon RW, Ensminger WD et al (1994) The anticancer drugs, 2nd edn. Oxford University Press, Oxford
43. Ren L, Liu T, Guo J et al (2010) A smart pH responsive graphene/polyacrylamide complex via noncovalent interaction. Nanotechnology 21:335701
44. Rice JR, Gerberich JL, Nowotnik DP (2006) Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system. Clin Cancer Res 12:2248–2254
45. Riley CM, Sternson LA (1985) Cisplatin analytical profiles of drug substances. Academic Press, New York, pp 77–105
46. Sun X, Liu Z, Welsher K et al (2008) Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 1:203–212
47. Tauro JR, Gemeinhart RA (2005) Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes. Bioconjug Chem 16:1133–1139
48. Tripisciano C, Borowiak-Palen E (2008) Cisplatin functionalized single-walled carbon nanotubes. phys status solidi (b) 245:1979–1982. doi:10.1002/pssb.200879558
49. Tripisciano C, Kraemer K, Taylor A et al (2009) Single-wall carbon nanotubes based anticancer drug delivery system. Chem Phys Lett 478:200–205
50. vanZutphen S, Reedijk J (2005) Targeting platinum anti-tumour drugs: overview of strategies employed to reduce systemic toxicity. Coord Chem Rev 249:2845–2853
51. Wang Y, Li Z, Wang J et al (2011) Graphene and graphene oxide: biofunctionalization an applications in biotechnology. Trends Biotechnol 29:205–212
52. Yan X, Gemeinhart RA (2005) Cisplatin delivery from Poly(acrylic acid-co-methyl methacrylate) microparticles. J Control Release 106:198–208
53. Yang X, Zhang X, Liu Z et al (2008) High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C 112:17554–17558
54. Yang K, Zhang S, Zhang G et al (2010) Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 10:3318–3323
55. Yang K, Wan J, Zhang S et al (2011) In vivo pharmacokinetics, long-term biodistribution, and oxicology of PEGylated graphene in mice. ACS Nano 5:516–522
56. Zhang L, Xia J, Zhao Q et al (2010a) Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6:537–544
57. Zhang F, Zheng B, Zhang J et al (2010b) Horseradish peroxidase immobilized on graphene oxide: physical properties and applications in phenolic compound removal. J Phys Chem C 114:8469–8473
58. Zhang J, Zhang F, Yang H et al (2010c) Graphene oxide as a matrix for enzyme immobilization. Langmuir 26:6083–6085
59. Zhang W, Guo Z, Huang D et al (2011) Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 32:8555–8561
60. Zhang Y, Nayak TR, Hong H et al (2012) Graphene: a versatile nanoplatform for biomedical applications. Nanoscale 4:3833–3842
61. Zhu S, Li J, Chen Y et al (2012) Grafting of graphene oxide with stimuli-responsive polymers by using ATRP for drug release. J Nanopart Res 14:1132